ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-145 Cr | ₹104 Cr | ₹11 Cr | ₹-2.34 Cr | ₹14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ERIS LIFESCIENCES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-145 Cr |
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹-2.34 Cr |
| Mar2022 | ₹14 Cr |
How is Net Cash Inflow / Outflow of ERIS LIFESCIENCES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-145 Cr | Negative | |
| Mar2025 | ₹104 Cr | 828.56 | |
| Mar2024 | ₹11 Cr | Positive | |
| Mar2023 | ₹-2.34 Cr | Negative | |
| Mar2022 | ₹14 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,392.2 Cr | 2.2% | -4.5% | -26.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 2.2% |
-4.5% |
-26.7% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses